Tue, April 19, 2022
Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022

Amit Hazan Maintained (TXG) at Hold with Decreased Target to $85 on, Apr 13th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-85-on-apr-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Amit Hazan of Goldman Sachs, Maintained "10x Genomics, Inc." (TXG) at Hold with Decreased Target from $95 to $85 on, Apr 13th, 2022.

Amit has made no other calls on TXG in the last 4 months.



There is 1 other peer that has a rating on TXG. Out of the 1 peers that are also analyzing TXG, 0 agree with Amit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Amit


  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $150 on, Thursday, February 17th, 2022

Publication Contributing Sources